Clinical Trials Directory

Trials / Unknown

UnknownNCT04848441

Risk of COVID-19 Infection After Vaccination

Risk of COVID-19 Infection After Vaccination: A Nationwide Study Comparing BNT162b2, mRNA-1273 and ChAdOx1

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000,000 (estimated)
Sponsor
Umeå University · Academic / Other
Sex
All
Age
0 Years – 110 Years
Healthy volunteers
Not accepted

Summary

The purpose of this observational nationwide study is to evaluate the effects of three different COVID-19 vaccines for the outcome of different severities of incident COVID infection.

Conditions

Interventions

TypeNameDescription
OTHERThe COVID-19 vaccines BNT162b2, mRNA-1273 and ChAdOx1The purpose of the study is to compare the effects of BNT162b2, mRNA-1273 and ChAdOx1 with respect to incident COVID-19 infection of different severities.

Timeline

Start date
2021-05-01
Primary completion
2021-08-01
Completion
2021-08-01
First posted
2021-04-19
Last updated
2021-04-19

Source: ClinicalTrials.gov record NCT04848441. Inclusion in this directory is not an endorsement.